Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Treatment for Pulmonary Sarcoidosis
NCT02265874Phase 2Completed
- Sponsor
- The Ohio State University
- Start
- Oct 2015
- Primary completion
- Nov 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in pulmonary sarcoidosis, sponsored by The Ohio State University. Started Oct 2015; status: completed.
02
Drugs
nicotine patch
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT02265874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02265874.